🚀 VC round data is live in beta, check it out!
Almoosa Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for Almoosa Health and similar public comparables like Draegerwerk, Surgery Partners, Akdital, Burjeel Holdings and more.
Almoosa Health Overview
About Almoosa Health
Almoosa Health Co provides integrated healthcare services that include primary, acute and rehabilitative care along with ancillary services such as pharmaceuticals, home healthcare and telemedicine. The company is also designing, constructing and developing hospitals care centers. The reported segments are: Medical Services and Hospital: Focused on delivering medical care and treatment; Rehabilitation Centre: Specializing in rehabilitation-related services; Pharmacy: Engaged in the sale of medicines.
Founded
1994
HQ
Employees
N/A
Website
Sectors
Financials (LTM)
EV
$2B
Almoosa Health Financials
Almoosa Health reported last 12-month revenue of $393M and negative EBITDA of ($88M).
In the same LTM period, Almoosa Health generated ($88M) in EBITDA losses and $58M in net income.
Revenue (LTM)
Almoosa Health P&L
In the most recent fiscal year, Almoosa Health reported revenue of — and net income of —.
Almoosa Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $393M | XXX | — | XXX | XXX | XXX |
| EBITDA | ($88M) | XXX | — | XXX | XXX | XXX |
| EBITDA Margin | (23%) | XXX | — | XXX | XXX | XXX |
| EBIT Margin | 16% | XXX | — | XXX | XXX | XXX |
| Net Profit | $58M | XXX | — | XXX | XXX | XXX |
| Net Margin | 15% | XXX | — | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Almoosa Health Stock Performance
Almoosa Health has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Almoosa Health's stock price is $40.06.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.0% | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAlmoosa Health Valuation Multiples
Almoosa Health trades at 4.9x EV/Revenue multiple, and (21.9x) EV/EBITDA.
EV / Revenue (LTM)
Almoosa Health Financial Valuation Multiples
As of March 7, 2026, Almoosa Health has market cap of $2B and EV of $2B.
Equity research analysts estimate Almoosa Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Almoosa Health has a P/E ratio of 30.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 4.9x | XXX | — | XXX | XXX | XXX |
| EV/EBITDA | (21.9x) | XXX | — | XXX | XXX | XXX |
| EV/EBIT | 30.9x | XXX | — | XXX | XXX | XXX |
| P/E | 30.4x | XXX | — | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Almoosa Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Almoosa Health Margins & Growth Rates
Almoosa Health's revenue in the last 12 month grew by 23%.
Almoosa Health's rule of 40 is 0% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Almoosa Health's rule of X is 34% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Almoosa Health Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 23% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Margin | (23%) | XXX | — | XXX | XXX | XXX |
| EBITDA Growth | 22% | XXX | (226%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 0% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 34% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Almoosa Health Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Draegerwerk | XXX | XXX | XXX | XXX | XXX | XXX |
| Surgery Partners | XXX | XXX | XXX | XXX | XXX | XXX |
| Akdital | XXX | XXX | XXX | XXX | XXX | XXX |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Select Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Almoosa Health M&A Activity
Almoosa Health acquired XXX companies to date.
Last acquisition by Almoosa Health was on XXXXXXXX, XXXXX. Almoosa Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Almoosa Health
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAlmoosa Health Investment Activity
Almoosa Health invested in XXX companies to date.
Almoosa Health made its latest investment on XXXXXXXX, XXXXX. Almoosa Health invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Almoosa Health
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Almoosa Health
| When was Almoosa Health founded? | Almoosa Health was founded in 1994. |
| Where is Almoosa Health headquartered? | Almoosa Health is headquartered in Saudi Arabia. |
| Who is the CEO of Almoosa Health? | Almoosa Health's CEO is Malek Abdulaziz Abdullah Almoosa. |
| Is Almoosa Health publicly listed? | Yes, Almoosa Health is a public company listed on Tadawul. |
| What is the stock symbol of Almoosa Health? | Almoosa Health trades under 4018 ticker. |
| When did Almoosa Health go public? | Almoosa Health went public in 2025. |
| Who are competitors of Almoosa Health? | Almoosa Health main competitors are Draegerwerk, Surgery Partners, Akdital, Burjeel Holdings. |
| What is the current market cap of Almoosa Health? | Almoosa Health's current market cap is $2B. |
| What is the current revenue of Almoosa Health? | Almoosa Health's last 12 months revenue is $393M. |
| What is the current revenue growth of Almoosa Health? | Almoosa Health revenue growth (NTM/LTM) is 23%. |
| What is the current EV/Revenue multiple of Almoosa Health? | Current revenue multiple of Almoosa Health is 4.9x. |
| Is Almoosa Health profitable? | No, Almoosa Health is not profitable. |
| What is the current EBITDA of Almoosa Health? | Almoosa Health has negative EBITDA and is not profitable. |
| What is Almoosa Health's EBITDA margin? | Almoosa Health's last 12 months EBITDA margin is (23%). |
| What is the current EV/EBITDA multiple of Almoosa Health? | Current EBITDA multiple of Almoosa Health is (21.9x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.